<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02674737</url>
  </required_header>
  <id_info>
    <org_study_id>Jinling37ICUCMH</org_study_id>
    <nct_id>NCT02674737</nct_id>
  </id_info>
  <brief_title>Evaluation of the Effect of Appropriate Sedation for Patients After Gastrectomy: A Prospective Randomised Controlled Study</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Chinese Medical Association</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Chinese Medical Association</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To evaluate the efficacy and safety of appropriate postoperative sedation with
      dexmedetomidine for patients after gastrectomy. Prospective randomised controlled study was
      conducted from October 2015 and December 2015 among patients after gastrectomy. The
      investigators are going to enroll patients who received abdominal surgeries. One group
      receive sedative along with analgesic and the other group analgesic only for the other group
      on the first 24 hours after surgeries and follow up for 3 days.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>January 2016</start_date>
  <primary_completion_date type="Anticipated">May 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>postoperative pain assessed by Prince Henry Pain Scale</measure>
    <time_frame>1-3d after gastrectomy</time_frame>
    <description>assessed by Prince Henry Pain Scale by investigators at 8:00 am after surgeries until discharge from ICU</description>
  </primary_outcome>
  <primary_outcome>
    <measure>recovery of gastrointestinal function assessed by time to first defecation after surgery</measure>
    <time_frame>30 days after gastrectomy</time_frame>
    <description>assessed by time to first defecation after surgery</description>
  </primary_outcome>
  <primary_outcome>
    <measure>white blood cell count (10^9/L)</measure>
    <time_frame>1-3d after gastrectomy</time_frame>
    <description>evaluate postoperative inflammatory response, blood sample collected at 6:00am for 1-3d after gastrectomy</description>
  </primary_outcome>
  <primary_outcome>
    <measure>C-reactive protein (mg/L)</measure>
    <time_frame>1-3d after gastrectomy</time_frame>
    <description>evaluate postoperative inflammatory response, blood sample collected at 6:00am for 1-3d after gastrectomy</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>percentage of time within target sedation range</measure>
    <time_frame>1-3d after gastrectomy</time_frame>
    <description>assessed by Richmond Agitation-Sedation Scale by investigators at 8:00 am after surgeries until discharge from ICU, the target range is âˆ’2 to +1</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>risk of bradycardia requiring interventions</measure>
    <time_frame>1-3d after gastrectomy</time_frame>
    <description>heart rate &lt;40/min is considered bradycardia</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>risk of hypotension requiring interventions</measure>
    <time_frame>1-3d after gastrectomy</time_frame>
    <description>systolic blood pressure &lt;80 mmHg or/and diastolic blood pressure &lt;50 mmHg is considered hypotension</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>use of opioids and use of benzodiazepins</measure>
    <time_frame>1-3d after gastrectomy</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Postoperative Sedation,Gastrectomy, Enhanced Recovery After Surgery</condition>
  <arm_group>
    <arm_group_label>Dexmedetomidine,tramadol and flurbiprofen</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Both sedative and analgesic(dexmedetomidine, tramadol and flurbiprofen) are applied to this group of patients.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Tramadol and flurbiprofen</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Only routine analgesic(tramadol and flurbiprofen) are applied to this group of patients.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>dexmedetomidine, tramadol and flurbiprofen</intervention_name>
    <arm_group_label>Dexmedetomidine,tramadol and flurbiprofen</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>tramadol and flurbiprofen</intervention_name>
    <arm_group_label>Tramadol and flurbiprofen</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18-85 years old

          -  underwent gastrectomy in the hospital and operation duration lasted at least 2 hours

        Exclusion Criteria:

          -  take part in other clinical trials

          -  quinolone antibiotics intake 4 weeks prior to or within the study

          -  NSAIDS intake within one month

          -  history of peptic ulcer

          -  respiratory insufficiency

          -  renal insufficiency

          -  acute hepatitis or severe liver disease (Child-Pugh class C)

          -  pregnancy or lactation

          -  abnormal ECG with clinical significance

          -  uncontrolled hypotension

          -  bleeding tendency or hematological diseases

          -  untreated mechanical intestinal obstruction

          -  unable to express or any kind of mental disease.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Minhua Cheng, M.D.</last_name>
    <phone>15951813384</phone>
    <email>cmhnju@163.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Wenkui Yu, Ph.D.</last_name>
    <phone>13701582986</phone>
    <email>yudrnj@163.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Institute of General Surgery of Jinling Hospital</name>
      <address>
        <city>Nanjing</city>
        <state>Jiangsu</state>
        <zip>210002</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Wenkui Yu, Ph.D.</last_name>
      <phone>13701582986</phone>
      <email>yudrnj@163.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>January 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 21, 2016</study_first_submitted>
  <study_first_submitted_qc>February 3, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 4, 2016</study_first_posted>
  <last_update_submitted>February 3, 2016</last_update_submitted>
  <last_update_submitted_qc>February 3, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 4, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Chinese Medical Association</investigator_affiliation>
    <investigator_full_name>Juanhong Shen</investigator_full_name>
    <investigator_title>Director, PhD, Principal Investigator, Resident Physician</investigator_title>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dexmedetomidine</mesh_term>
    <mesh_term>Flurbiprofen</mesh_term>
    <mesh_term>Tramadol</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Main results and conclusion will be available</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

